Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
WIN consortium as a basis for forming cross-border collaborations for improving ...
Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA
WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care ( Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA )
26 Jun 2014
T-VEC injections into melanoma lesions show significant response rate
Prof Kevin Harrington - Institute of Cancer Research, London, UK
T-VEC injections into melanoma lesions show significant response rate ( Prof Kevin Harrington - Institute of Cancer Research, London, UK )
2 Jun 2014
History and ongoing work of AORTIC
Dr James Holland - Mount Sinai Hospital, New York, USA
History and ongoing work of AORTIC ( Dr James Holland - Mount Sinai Hospital, New York, USA )
5 May 2014
AORTIC and the benefits of coordination between different US NCI-designated canc...
Dr Lisa Stevens - National Cancer Institute, Bethesda, USA
AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya ( Dr Lisa Stevens - National Cancer Institute, Bethesda, USA )
5 May 2014
Role of AORTIC in dealing with rising cancer rates in Africa
North American Vice president of AORTIC
Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )
1 May 2014
Prevention of cervical cancer through control of HPV virus
Dr Margaret Stanley - Department of Pathology, University of Cambridge, Cambridg...
Prevention of cervical cancer through control of HPV virus ( Dr Margaret Stanley - Department of Pathology, University of Cambridge, Cambridge, United Kingdom )
11 Apr 2014
Biomarker development for ipilimumab and prostate GVAX treatment
Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlan...
Biomarker development for ipilimumab and prostate GVAX treatment ( Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlands )
26 Mar 2014
Toll like receptor 7 agonists for cancer immunotherapy
Prof Stefan Endres - Ludwig-Maximilians-Universität, Munich, Germany
Toll like receptor 7 agonists for cancer immunotherapy ( Prof Stefan Endres - Ludwig-Maximilians-Universität, Munich, Germany )
25 Mar 2014
The 1st Immunotherapy of Cancer Conference (ITOC)
Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria
The 1st Immunotherapy of Cancer Conference (ITOC) ( Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria )
25 Mar 2014
Reasons for combining immunotherapy with chemo to enhance anti tumour response
Prof Angus Dalgleish - St George's, University of London, London, UK
Reasons for combining immunotherapy with chemo to enhance anti tumour response ( Prof Angus Dalgleish - St George's, University of London, London, UK )
25 Mar 2014
Dendritic cell vaccination combined with CTLA4 blockade
Dr Kris Thielemans - Medical School of the VUB, Brussels, Belgium
Dendritic cell vaccination combined with CTLA4 blockade ( Dr Kris Thielemans - Medical School of the VUB, Brussels, Belgium )
25 Mar 2014
mRNA-based cancer vaccines
Dr Karl-Josef Kallen - Principal Scientific Fellow, CureVac Gmbh
mRNA-based cancer vaccines ( Dr Karl-Josef Kallen - Principal Scientific Fellow, CureVac Gmbh )
24 Mar 2014